Susanne Kossatz

Innsbruck Medical University — Austria

Medicine · Health Sciences

29h-index2.9kcitations138works1.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

PARP inhibition in cancer therapy(49), Cell Adhesion Molecules Research(18), Glioma Diagnosis and Treatment(17), Radiopharmaceutical Chemistry and Applications(14), DNA Repair Mechanisms(13)

Publications138 total

Synthesis and preclinical development of a novel 68Ga/89Zr-Labelled ανβ6-integrin targeting trimer
EJNMMI Radiopharmacy and Chemistry·2026Open Access
Chimeric peptide-based radiopharmaceuticals for glioblastoma imaging and therapy by targeting mHsp70 and enhancing BBB penetration
2026
Digital Twins for Radiopharmaceutical Dosimetry: PBPK Modelling of [177Lu]Lu-rhPSMA-10.1 in a Preclinical mCRPC Model
Cancers·2025Open Access
Development of a neuroimaging biomarker of the pro‐coagulant state in Alzheimer's disease: The BioClotAD Project
Alzheimer s & Dementia·2025Open Access
Development of a neuroimaging biomarker of the pro‐coagulant state in Alzheimer’s disease: The BioClotAD Project
Alzheimer s & Dementia·2025Open Access
Synthesis and Preclinical Development of a Novel <sup>68</sup> Ga/ <sup>89</sup> Zr-Labelled ανβ6-Integrin Targeting Trimer
2025Open Access
Peroxiredoxin IV (PRDX4) as new molecular target for radioimmunoimaging and -therapy in cancer
Nuclear Medicine and Biology·2025Open Access
Novel SSTR2-targeted peptide-drug conjugates for improved PARPi delivery
Nuclear Medicine and Biology·2025Open Access
Development of novel trimeric Radioligands targeting the Fibroblast Activation Protein for Therapy
Nuclear Medicine and Biology·2025Open Access
A Small Molecule Drug-Based Ru(II) Polypyridine Mass-Tag for Multimodal Imaging of Tissue Samples
ACS Central Science·2025Open Access
[<sup>225</sup>Ac]Ac-PSMA I&amp;T: A Preclinical Investigation on the Fate of Decay Nuclides and Their Influence on Dosimetry of Salivary Glands and Kidneys
Journal of Nuclear Medicine·2025
A small molecule drug-based Ru(II) polypyridine mass-tag for multimodal imaging of tissue samples
2025Open Access
PET-based tracking of CAR T cells and viral gene transfer using a cell surface reporter that binds to lanthanide complexes
Nature Biomedical Engineering·2025· 5 citedOpen Access
Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells
Theranostics·2025· 1 citedOpen Access
Expanding a Mathematical Model for Investigating Combined Radiopharmaceutical and Immune Checkpoint Therapy
Nuklearmedizin - NuclearMedicine·2025
Investigation on the preclinical biokinetics of [177Lu]Lu-rhPSMA-10.1 via a physiologically-based pharmacokinetic model
Nuklearmedizin - NuclearMedicine·2025
A mathematical model for the investigation of combined treatment of radiopharmaceutical therapy and PARP inhibitors
European Journal of Nuclear Medicine and Molecular Imaging·2025· 2 citedOpen Access
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands
Journal of Medicinal Chemistry·2025· 3 citedOpen Access
Isopeptidic Desferrioxamine Analogues: The Role of Hydroxamate Spacing for Chelation of Zr<sup>4+</sup>
ChemMedChem·2024· 1 citedOpen Access
Three Is a Magic Number: Tailored Clickable Chelators Used to Determine Optimal RGD-Peptide Multiplicity in αvβ6-Integrin Targeted <sup>177</sup>Lu-Labeled Cancer Theranostics
Bioconjugate Chemistry·2024· 6 cited
page 1 of 7Next →

Frequent Co-authors

Thomas Reiner(33), Wolfgang Weber(16), Brandon Carney(11), Giacomo Pirovano(9), Paula Demétrio De Souza França(9), Christian Brand(9), Navjot Guru(8), Sheryl Roberts(8), Jason S. Lewis(6), Snehal G. Patel(6), Ingrid Hilger(5), Ahmad Sadique(5), Patrick L. Donabedian(5), Stephen A. Jannetti(4), Lukas M. Carter(4), Giuseppe Carlucci(4), Mithat Gönen(4), Daniella K. Zanoni(4), Audrey Mauguen(4), Ian Ganly(4)